Skip to main content

Havencrest Healthcare Partners, L.P.'s Form 4 filing

Starling Oncology, Inc.DFPH · filed Jan 30, 2024

Accession no.
0000950170-24-009050
Filed
Jan 30, 2024, 7:07 PM ET
Trade date
Jan 29, 2024
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $18.3K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Havencrest Healthcare Partners, L.P.CIK 000170574810% Owner
Toi HC I, LLCCIK 000189215410% Owner
Havencrest Healthcare Partners GP, LLCCIK 000189372210% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 29, 2024Common stockSSaleDisposed−8,637$2.12F1−$18,310.440Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.19, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Referenced by the price of 1 transaction in Table I.

Remarks

Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

Read the full filing on SEC EDGAR (opens in a new tab)